{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T05:10:53Z","timestamp":1741497053621,"version":"3.38.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Particle Therapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijpt.2025.100740","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T17:19:42Z","timestamp":1739380782000},"page":"100740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Application of Photon-Derived Worst-Case Robustness Criteria to Proton Therapy Planning"],"prefix":"10.1016","volume":"15","author":[{"given":"Krishmita","family":"Siwakoti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison P.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared A.","family":"Maas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel R.","family":"Marcrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rex A.","family":"Cardan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Harms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B.","family":"Fiveash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7931-8841","authenticated-orcid":false,"given":"Adam J.","family":"Kole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpt.2025.100740_bib1","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1088\/0031-9155\/51\/9\/009","article-title":"Simulation and visualization of dose uncertainties due to interfractional organ motion","volume":"51","author":"Maleike","year":"2006","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijpt.2025.100740_bib2","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0360-3016(00)00518-6","article-title":"The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy","volume":"47","author":"van Herk","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2025.100740_bib3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1088\/0031-9155\/53\/4\/014","article-title":"Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: the potential effects of calculational uncertainties","volume":"53","author":"Lomax","year":"2008","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijpt.2025.100740_bib4","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1088\/0031-9155\/53\/4\/015","article-title":"Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions","volume":"53","author":"Lomax","year":"2008","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijpt.2025.100740_bib5","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1088\/0031-9155\/52\/10\/009","article-title":"Accounting for range uncertainties in the optimization of intensity modulated proton therapy","volume":"52","author":"Unkelbach","year":"2007","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijpt.2025.100740_bib6","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.canrad.2020.06.016","article-title":"Time of PTV is ending, robust optimization comes next","volume":"24","author":"Biston","year":"2020","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijpt.2025.100740_bib7","doi-asserted-by":"crossref","first-page":"22TR02","DOI":"10.1088\/1361-6560\/aae659","article-title":"Robust radiotherapy planning","volume":"63","author":"Unkelbach","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijpt.2025.100740_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110365","article-title":"Robustness evaluation of pencil beam scanning proton therapy treatment planning: a systematic review","volume":"197","author":"Sterpin","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijpt.2025.100740_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.radonc.2022.06.005","article-title":"Plan quality assessment in clinical practice: results of the 2020 ESTRO survey on plan complexity and robustness","volume":"173","author":"Kaplan","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijpt.2025.100740_bib10","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1016\/j.prro.2023.09.002","article-title":"Characterization of photon intensity modulated radiation therapy robustness in patients with prostate cancer as a proposed benchmark for proton therapy robustness evaluation","volume":"14","author":"Maas","year":"2024","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijpt.2025.100740_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.rpor.2016.01.002","article-title":"Image-guided hypofractionated proton beam therapy for low-risk prostate cancer: analysis of quality of life and toxicity, PCG GU 002","volume":"21","author":"Vargas","year":"2016","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.ijpt.2025.100740_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3857\/roj.2021.00388","article-title":"Dose-volume histogram parameters and patient-reported EPIC-bowel domain in prostate cancer proton therapy","volume":"39","author":"Bulman","year":"2021","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.ijpt.2025.100740_bib13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/jrr\/rrae026","article-title":"Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial","volume":"65","author":"Murakami","year":"2024","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijpt.2025.100740_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijrobp.2007.03.018","article-title":"Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison","volume":"69","author":"Trofimov","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2025.100740_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijrobp.2010.09.024","article-title":"Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer","volume":"82","author":"Mendenhall","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2025.100740_bib16","unstructured":"COMPPARE Trial. ClinicalTrials.gov ID NCT03561220.\u00a0Accessed November 1,\u00a02024. https:\/\/clinicaltrials.gov\/study\/NCT03561220."},{"key":"10.1016\/j.ijpt.2025.100740_bib17","unstructured":"PARTIQoL Trial. ClinicalTrials.gov ID NCT01617161.\u00a0Accessed November 1,\u00a02024. https:\/\/clinicaltrials.gov\/study\/NCT01617161."},{"key":"10.1016\/j.ijpt.2025.100740_bib18","unstructured":"NRG-GU010 Trial. ClinicalTrials.gov ID NCT05050084.\u00a0Accessed November 1,\u00a02024. https:\/\/clinicaltrials.gov\/study\/NCT05050084."},{"key":"10.1016\/j.ijpt.2025.100740_bib19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.clon.2020.03.014","article-title":"Comparing proton to photon radiotherapy plans: UK consensus guidance for reporting under uncertainty for clinical trials","volume":"32","author":"Lowe","year":"2020","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijpt.2025.100740_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jmrs.224","article-title":"Initial experience with intra-fraction motion monitoring using Calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment","volume":"64","author":"Bell","year":"2017","journal-title":"J Med Radiat Sci"},{"key":"10.1016\/j.ijpt.2025.100740_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150326","article-title":"Quantification and assessment of interfraction setup errors based on cone beam CT and determination of safety margins for radiotherapy","volume":"11","author":"Cubillos Mesias","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpt.2025.100740_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijrobp.2007.08.040","article-title":"Planning target margin calculations for prostate radiotherapy based on intrafraction and interfraction motion using four localization methods","volume":"70","author":"Beltran","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2025.100740_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040925","article-title":"Proton therapy for prostate cancer: challenges and opportunities","volume":"14","author":"Poon","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ijpt.2025.100740_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.radonc.2021.08.016","article-title":"Does the uncertainty in relative biological effectiveness affect patient treatment in proton therapy?","volume":"163","author":"Sorensen","year":"2021","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Particle Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518025000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518025000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T03:05:10Z","timestamp":1741489510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2331518025000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":24,"alternative-id":["S2331518025000034"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpt.2025.100740","relation":{},"ISSN":["2331-5180"],"issn-type":[{"type":"print","value":"2331-5180"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of Photon-Derived Worst-Case Robustness Criteria to Proton Therapy Planning","name":"articletitle","label":"Article Title"},{"value":"International Journal of Particle Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpt.2025.100740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Particle Therapy Co-operative Group.","name":"copyright","label":"Copyright"}],"article-number":"100740"}}